Phio Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Dec 22 | BuyUS$780 | Robert Bitterman | Individual | 166.67 | US$4.68 | |
07 Dec 22 | BuyUS$780 | Robert Bitterman | Individual | 166.67 | US$4.68 | |
05 Dec 22 | BuyUS$860 | Robert Bitterman | Individual | 166.67 | US$5.16 | |
02 Dec 22 | BuyUS$2,041 | Robert Ferrara | Individual | 416.67 | US$4.90 | |
29 Nov 22 | BuyUS$1,136 | Robert Bitterman | Individual | 226.25 | US$5.04 | |
23 Nov 22 | BuyUS$820 | Robert Ferrara | Individual | 166.67 | US$4.92 |
Insider Trading Volume
Insider Buying: PHIO insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 11,601 | 1.0% |
Institutions | 60,633 | 5.3% |
General Public | 1,066,763 | 93.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,182 | $113.1k | -26.77% | no data | |||
17,799 | $110.7k | -9.05% | no data | |||
8,932 | $55.6k | 0% | no data | |||
6,249 | $38.9k | 0% | no data | |||
3,210 | $20.0k | 0% | no data | |||
2,045 | $12.7k | 55.04% | no data | |||
1,933 | $12.0k | -16.54% | no data | |||
1,903 | $11.8k | 0.42% | no data | |||
1,859 | $11.6k | 116.67% | no data | |||
1,667 | $10.4k | 53.92% | no data | |||
1,621 | $10.1k | 26.64% | no data | |||
1,523 | $9.5k | 0% | no data | |||
1,048 | $6.5k | 0% | no data | |||
1,039 | $6.5k | 0% | no data | |||
864 | $5.4k | 0% | no data | |||
864 | $5.4k | 0% | no data | |||
836 | $5.2k | 0% | no data | |||
455 | $2.8k | -33.19% | no data | |||
125 | $777.7 | 0.81% | no data | |||
72 | $448.0 | 0% | no data | |||
7 | $43.6 | 75% | no data | |||
1 | $6.2 | 0% | no data |